Summit Therapeutics PLC ORD 1P

(LSE, Stocks) 
p 22.00 <%= Resources.Global.txtDown %>
Updated 13/06/2019
Change % -4.35% Stock price decreasing
Change -1.00 Stock price decreasing
Volume 27,277
High P 22.49
Low P 21.04
Open P 22.00
Prev close P 23.00
# of shares 160.49M
Market cap 3,530.88M GBX

Market closed
Summit Therapeutics PLC ORD 1P
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  22.00 -4.3% Stock price decreasing -17.0% Stock price decreasing -30.2% Stock price decreasing 22.2% Stock price increasing -88.7% Stock price decreasing
Powered by TradingView

News about Summit Therapeutics PLC ORD 1P

  • English
  • Regulatory news

Company profile

Summit Therapeutics PLC is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of medicines for indications for which there inadequate or no therapies. It also conducts clinical programs focused on the genetic disease Cuchenne muscular dystrohy and the infectious disease Clostridium difficile infection. The company has drug development segment. Its all assets are located in the United Kingdom.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
16 June 2019 18:38:07
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB3 - 2019-06-16 19:38:07 - 2019-06-16 18:38:07 - 1000 - Website: OKAY